MODULATION OF EXTRACELLULAR KINASE ACTIVITY AND FUNCTION FOR TREATMENT OF PAIN AND NEURODEGENERATIVE/NEUROIMMUNE DISEASE

ANTI-WARS1 ANTIBODY AND USE THEREOF

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

ANTI-CD3E/BCMA BISPECIFIC ANTIBODY AND USE THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES THEREOF

HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY

INTEGRIN ALPHA-7 BETA-1 ANTIBODIES AND USES THEREOF

ANTIBODIES

ACTIVATABLE MASKED ANTI-CTLA4 BINDING PROTEINS

ANTI-CD300C ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USES THEREOF FOR PREVENTING OR TREATING DEGENERATIVE BRAIN DISEASE

ANTI-NOTCH3 ANTIBODIES

NOVEL ANTIGEN BINDING MOLECULE FORMATS

USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS

Antibodies to Amyloid Beta

CONNEXIN 43 ANTIBODIES AND USE THEREOF

METHODS FOR TREATMENT USING ANTI-ALPHA4BETA7 ANTIBODY

PHARMACEUTICAL COMPOSITION, MEGASPHAERA, AND USE THEREOF

BISPECIFIC ANTIBODIES BINDING TO HER-3 AND TO EITHER HER-2 OR EGFR

Anti-PSMA Antibodies, Bispecific Antigen-Binding Molecules that Bind PSMA and CD3, and Uses Thereof

BISPECIFIC ANTIBODY

ANTIBODIES AND VACCINES FOR USE IN TREATING ROR1 CANCERS AND INHIBITING METASTASIS

COMPOSITIONS AND METHODS FOR SELECTIVE REGULATION OF VASCULAR PERMEABILITY

PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES

ANTI-BCMA ANTIBODIES

PHARMACEUTICAL FORMULATION COMPRISING ANTI-OX40 MONOCLONAL ANTIBODY

ANTIBODIES AND BISPECIFIC BINDING PROTEINS THAT BIND OX40 AND/OR PD-L1

COMPOSITIONS AND METHODS FOR MODULATING ANTIGEN BINDING ACTIVITY

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME

PHARMACEUTICAL COMBINATION AND USE THEREOF

CTLA4-BINDING PROTEINS AND METHODS OF TREATING CANCER

HETEROMULTIMER BINDING DLL3 AND CD3

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

Pharmaceutical Composition for Preventing or Treating Sjogren's Syndrome Comprising Anti-SEMA4D Blocking Antibody as Active Ingredient

COMBINATION OF ANTIBODY-DRUG CONJUGATE AND ANTI-SIRPa ANTIBODY

SUBCUTANEOUS ADMINISTRATION OF CD19-BINDING T CELL ENGAGERS

ZIP12 ANTIBODY

MFAP4 AND TREATMENT OF FIBROSIS

USE OF IL-36 INHIBITORS FOR THE TREATMENT OF NETHERTON SYNDROME

INHIBITORS OF COMPLEMENT FACTOR H

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SYSTEM ATROPHY (MSA)

TAU BINDING COMPOUNDS

UTILIZATION OF IMMORTALIZED B CELLS TO IDENTIFY SDCBP AS A NOVEL THERAPEUTIC TARGET IN OVARIAN CARCINOMA

Monoclonal Antibody A38 Against Rift Valley Fever Virus and Use

EXTRACELLULAR VESICLE COMPOSITES AND THEIR USES IN THE TREATMENT OF LIVER INJURY

LGALS3BP ANTIBODY-DRUG-CONJUGATE AND ITS USE FOR THE TREATMENT OF CANCER

P2RY2 ACTIVITY MODULATORS

STABLE FORMULATIONS FOR TNF-alpha ANTIBODIES AND USES THEREOF

ANTI-HUMAN CD45RC BINDING DOMAINS AND USES THEREOF

APPLICATION OF HYDROXYPROGESTERONE CAPROATE IN ENHANCING TUMOR TREATMENT EFFECT

METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST

ANTIBODY USED TO TREAT CORONAVIRUS INFECTION

MONOCLONAL ANTIBODY AGAINST HUMAN ACTIVATED PROTEIN C AND PREPARATION AND USE THEREOF

PSMA ANTIBODIES AND USES THEREOF

ANTI-CD38 ANTIBODIES, ANTI-CD3 ANTIBODIES, AND BISPECIFIC ANTIBODIES, AND USES THEREOF

THE USE OF CD40 INHIBITORS FOR INHIBITING AN IMMUNE RESPONSE AND ENABLING IMMUNOGEN ADMINISTRATION AND RE-ADMINISTRATION

ANTIBODY-BASED SOLUBLE AND MEMBRANE-BOUND TWEAK MIMICKING AGONISTS WITH FCYR-INDEPENDENT ACTIVITY

DEVELOPMENT AND APPLICATION OF T-CELL ENGAGER THERAPEUTIC AGENT

ANTIBODY SPECIFICALLY BINDING TO 4-1BB AND ANTIGEN-BINDING FRAGMENT OF ANTIBODY

POLYNUCLEOTIDES ENCODING, AND METHOD OF MAKING, A POLYPEPTIDE COMPRISING A VHH WHICH BINDS INTERLEUKIN- RECEPTOR (IL-7R)

TREATMENT OF PRURITIS EMPLOYING ANTI-IL13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF

AGENT, USES AND METHODS FOR TREATMENT

CANINE PD-L1 ANTIBODY, ANTIGEN BINDING FRAGMENTS THEREOF, AND METHODS OF USE THEREOF

ANTIBODIES SPECIFIC TO PD-1 AND METHODS OF USE

ANTI-CD8 ALPHA DEPLETING ANTIBODIES

ANTIBODIES BINDING TO CD3 and CD19

TIM-3-TARGETING ANTIBODIES AND USES THEREOF

ANTI-ILT3 ANTIBODIES AND USE THEREOF

ANTIBODY SPECIFICALLY BINDING TO CD47 AND ANTIGEN-BINDING FRAGMENT THEREOF

ANTI-NAPI2B ANTIBODIES AND METHODS OF USE

CANNABINOID TYPE 1 RECEPTOR BINDING PROTEINS AND USES THEREOF

ANTIBODY OR ANTIBODY FRAGMENT THAT SPECIFICALLY BINDS TO VOLTAGE-GATED SODIUM CHANNEL ALPHA SUBUNIT NAV1.7

ANTIBODIES SPECIFICALLY RECOGNIZING THYMIC STROMAL LYMPHOPOIETIN AND USES THEREOF

Methods for Preventing and Treating Cardiac Dysfunction and COVID-19 with Activin A Antagonists

ANTI-GDF-15 ANTIBODIES

Albumin-Binding Polypeptides and Uses Thereof

COMPOSITIONS AND METHODS FOR TREATING EYE DISEASES

HUMAN MONOCLONAL ANTIBODIES TO EASTERN EQUINE ENCEPHALITIS VIRUS AND USES THEREFOR

ANTI-ALPP/ALPPL2 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

SELECTIVELY ALTERING MICROBIOTA FOR IMMUNE MODULATION

THERAPEUTIC METHODS AND AGENTS FOR THE TREATMENT OF MYOCARDIAL INFARCTION

APPLICATION OF BIFIDOBACTERIUM ANIMALIS IN IMPROVEMENT OF TUMOR IMMUNOTHERAPY RESPONSE

USE OF LITHIUM-CONTAINING COMPOUNDS IN TREATMENT OF TUMORS

USE OF ONVANSERTIB AS MONOTHERAPY AND IN COMBINATION WITH CETUXIMAB IN TREATING RAS WILD-TYPE COLORECTAL CANCER

GENE MUTATIONS AND COPY NUMBER ALTERATIONS OF EGFR, KRAS AND MET

VIRAL DELIVERY OF NEOANTIGENS

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

CD98HC ANTIGEN-BINDING DOMAINS AND USES THEREFOR

TRANSFERRIN RECEPTOR ANTIGEN-BINDING DOMAINS AND USES THEREFOR

ANTIBODIES FOR T-CELL ACTIVATION

ANTI-TL1A ANTIBODIES FOR THE TREATMENT OF ULCERATIVE COLITIS AND CROHN'S DISEASE

METHODS OF TREATING INFLAMMATION

ALK2 ANTIBODIES AND METHODS OF USE THEREOF

KLRB1 BINDING AGENTS AND METHODS OF USE THEREOF

METHODS OF TREATING RESPIRATORY DISORDERS

ANTIBODY MOLECULES

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

METHODS OF TREATING LUNG CANCER BY ADMINISTERING A PD-1 INHIBITOR

MULTISPECIFIC ANTIBODIES AND USES THEREOF

CLDN18.2 ANTIBODY AND USE THEREOF

MONOCLONAL ANTIBODIES AGAINST ENDOTROPHIN AND THE USE THEREOF

ANTIBODIES AND METHODS TARGETING INTERLEUKIN-19

ANTIBODIES AND USES THEREOF

ANTI-NETRIN-4 ANTIBODY AND USE THEREOF

ANTI-ACTIVIN ANTIBODIES AND METHODS OF USING THE SAME

ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF

TAU BINDING MOLECULES

ANTIBODY MOLECULES AND USES THEREOF

MULTIVALENT ANTI-CAMPYLOBACTER ANTIBODIES AND VACCINE

SYSTEMS, DEVICES AND METHODS FOR APPLYING ANTI-VEGF COMPOUNDS AND USING SUCH COMPOUNDS TO TREAT SKIN CONDITIONS

Afucosylated Anti-FGFR2IIIB Antibodies

Treatment and Prophylaxis of Amyloidosis

COMBINATION THERAPY USING A SUBSTITUTED PYRIMIDIN-4(3H)-ONE AND NIVOLUMAB AS WELL AS ITS USE IN THE TREATMENT OF CANCER

COMBINATION OF DUAL ATM AND DNA-PK INHIBITORS AND IMMUNOTHERAPEUTIC AGENTS FOR USE IN CANCER THERAPY

METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS

Anti-CD98hc VNARs for Crossing the Blood Brain Barrier and Type IV VNAR Libraries

ANTI-CD24 ANTIBODY AND USE THEREOF

COMPOSITIONS AND METHODS OF TREATING CHILDHOOD ONSET IDIOPATHIC NEPHROTIC SYNDROME

THERAPEUTIC AGENT FOR NK-CELL TUMOR

ANTIBODIES, USES & METHODS

ANTI-EGFR ANTIBODY DRUG CONJUGATES

Cation-Independent Mannose-6-Phosphate Receptor Binders

METHODS AND SYSTEMS FOR IDENTIFYING OR TREATING CENTRAL NERVOUS SYSTEMS DISEASE

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

Clazakizumab in the Treatment of Chronic Antibody-Mediated Rejection of Organ Transplant

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

NEUTRALIZING ANTIBODIES TO PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE PROTEIN AND THEIR USE

ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF

Anti-P53 Antibodies

TREATING REFRACTORY MIGRAINE

BISPECIFIC BINDING AGENT

COMPOSITIONS AND METHODS FOR TREATING AND SUPPRESSING ALLERGIC RESPONSES

NEUTRALIZING ANTI-INFLUENZA B ANTIBODIES AND USES THEREOF

BINDING MOLECULE HAVING NEUTRALIZING ACTIVITY AGAINST CORONAVIRUS SUPERFAMILY

ANTIBODY THERAPIES FOR SARS-COV-2 INFECTION

BIFUNCTIONAL MOLECULE FORMED BY FUSION OF PD1 ANTIBODY AND INTERLEUKIN 2

FLUOROCHEMICAL TARGETED THERAPIES

THERAPEUTIC RNA FOR HPV-POSITIVE CANCER

METHOD OF ADMINISTRATION AND TREATMENT

Anti-FOLR1 Immunoconjugate Dosing Regimens

PHARMACEUTICAL FOR TREATING OR PREVENTING CANCER

AQUEOUS PHARMACEUTICAL COMPOSITION OF ANTI-PD1 ANTIBODY PROLGOLIMAB AND USE THEREOF

Genome-Based Methods For Reducing Cardiovascular Risk

METHODS AND COMPOSITIONS FOR TREATING CANCER

ANTI-MUC1 ANTIBODY

ADAMTS Binding Immunoglobulins

HIGH CONCENTRATION ANTIBODY-CONTAINING LIQUID FORMULATION

BISPECIFIC AGONISTIC ANTIBODIES TO ACTIVIN A RECEPTOR LIKE TYPE 1 (ALK1)

FUSION PROTEIN PLATFORM HAVING IMPROVED HALF-LIFE

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

NOVEL ANTIBODIES AND NUCLEOTIDE SEQUENCES, AND USES THEREOF

THERAPEUTIC AND DIAGNOSTIC METHODS FOR BLADDER CANCER

ANTI-Vbeta17/ANTI-CD123 BISPECIFIC ANTIBODIES

Anti-CD47/Anti-CLDN18.2 Bispecific Antibody and Use Thereof

THERAPEUTIC ANTIBODIES

ANTIBODIES SPECIFIC FOR HYPERPHOSPHORYLATED TAU AND METHODS OF USE THEREOF

ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS PAN-SPECIFICALLY BINDING TO GREMLIN-1 AND GREMLIN-2 AND USES THEREOF

METHOD OF TREATING UVEITIS WITH MULTIVALENT PROTEIN-HYALURONIC ACID POLYMER CONJUGATE

DUAL AND TRIPLE HAPTEN CONJUGATES, COMPOSITIONS, PROCESSES FOR MAKING, AND METHODS OF TREATMENT THEREWITH

COMPOSITIONS AND METHODS FOR TUMOR IMMUNOTHERAPY

COMPOSITIONS AND METHODS FOR IMMUNE-MEDIATED CANCER THERAPY

Atomic Description of Immune Complex that Causes Heparin-Induced Thrombocytopenia

APOE GENOTYPING IN CANCER PROGNOSTICS AND TREATMENT

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

ANTI-PLA2G10 ANTIBODIES AND METHODS OF USE

CHIMERIC RECEPTORS TARGETING ADGRE2 AND/OR CLEC12A AND USES THEREOF

ANTIBODIES TARGETING SIRP-ALPHA AND USES THEREOF

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

Bispecific Binding Molecules That Target FSHR and CD3

ANTI-C-C MOTIF CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES AND METHODS OF USE

ANTI-SOLUBLE INTERLEUKIN-7 RECEPTOR ANTIBODY THERAPY TO TREAT AUTOIMMUNE DISEASES

SIL-6R AND CTGF BINDING PROTEINS AND METHODS OF USE THEREOF

Antibodies Directed To Tie-2 and VEGF and Methods of Use

CANNABINOID RECEPTOR TYPE 1 (CB1) BINDING PROTEINS AND USES THEREOF

METHODS AND COMPOSITIONS COMPRISING PURIFIED RECOMBINANT POLYPEPTIDES

BIOMARKER-BASED TREATMENT AND DIAGNOSTIC METHODS FOR IL-17-DEPENDENT CONDITIONS

Antigen Binding Proteins

YOLK IMMUNOGLOBULIN (IgY) AGAINST COXSACKIEVIRUS A16 AND/OR ENTEROVIRUS A71 AND ITS PREPARATION AND USES THEREOF

PASSIVE IMMUNIZATION WITH ANTI-AAV NEUTRALIZING ANTIBODIES TO PREVENT OFF-TARGET TRANSDUCTION OF INTRATHECALLY DELIVERED AAV VECTORS

MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING DYSTROPHINOPATHIES

High Concentratioin Anti-BLYS Pharmaceutical Formulations

CYTOKINE ENGAGERS AND USES THEREOF

ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING COLORECTAL CANCER, COMPRISING ESTROGEN AND ANTI-PD-L1 ANTIBODY

SIK3 INHIBITORS FOR TREATING DISEASES RESISTANT TO DEATH RECEPTOR SIGNALLING

COMBINATION USES OF NITROXOLINE AND ITS ANALOGUES WITH CHEMOTHERAPIES AND IMMUNOTHERAPIES IN THE TREATMENT OF CANCERS

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

SINGLE-DOMAIN ANTIBODIES AND VARIANTS THEREOF AGAINST OPIOIDS

METHODS TO REGULATE GLYCOLYSIS VIA TARGETING EXTRACELLULAR ALPHA-ENOLASE FOR TREATING HUMAN DISEASES

ANTI-CD24 COMPOSITIONS AND USES THEREOF

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

ANTI-CCR8 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF

CAR-EXPRESSING CELLS AGAINST MULTIPLE TUMOR ANTIGENS AND USES THEREOF

TREATMENT OF SOLID TUMORS

ACTIVATABLE ANTI-CD3, ANTI-EGFR, HETEROMULTIMERIC BISPECIFIC POLYPEPTIDE COMPLEX

METHODS OF TREATING INFLAMMATORY DISEASES BY BLOCKING GALECTIN-3

ANTI-CD161 ANTIBODIES AND USES THEREOF

METHODS OF TREATING GASTROINTESTINAL INFLAMMATORY DISEASE

ANTI-B7H3 ANTIBODIES AND METHODS OF USE

Compositions for Redirecting Immunoglobulins to Immune Cells

EPITOPE OF REGULATORY T CELL SURFACE ANTIGEN, AND ANTIBODY SPECIFICALLY BINDING THERETO

PREDICTION AND TREATMENT OF FAST PROGRESSING RENAL DISEASE

ANTI-FSH ANTIBODIES FOR NEURODEGENERATIVE DISEASES

ENGINEERED ANTI-IL-2 ANTIBODIES

COMBINATION OF A GREMLIN-1 ANTAGONIST WITH A CYTIDINE ANALOGUE OR DEOXYCYTIDINE ANALOGUE

ANTI-C3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS THEREOF AND THEIR USES FOR TREATING EYE OR OCULAR DISEASES

COMBINATION THERAPIES USING ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

T-Cell Modulatory Multimeric Polypeptides and Methods of Use Thereof

METHODS AND COMPOSITIONS FOR USING PLASMA CELL DEPLETING AGENTS AND/OR B CELL DEPLETING AGENTS TO SUPPRESS HOST ANTI-AAV ANTIBODY RESPONSE AND ENABLE AAV TRANSDUCTION AND RE-DOSING

DNA THERAPEUTIC ENCODING AN ANTIBODY OR ANTIGEN BINDING FRAGMENT

COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER

COMBINATION THERAPIES BASED ON PD-1 INHIBITORS AND SIK3 INHIBITORS

COMPOSITIONS AND METHODS FOR TREATING IMMUNOLOGICAL DYSFUNCTION

COMPOSITION AND METHOD FOR INHIBITING FIBROSIS

HEAVY CHAIN ANTIBODIES BINDING TO PSMA

ANTI-PSMA ANTIBODIES, VARIANTS, AND USES THEREOF

ANTI-DLL3 ANTIBODY

Stabilized Formulations Containing Anti-CD20 x Anti-CD3 Bispecific Antibodies

TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRBeta ANTIBODY

Antibodies Against Human Siglec-7 and Use Thereof for Immunotherapy

Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor

ANTIBODIES AND METHODS OF MAKING AND USING SAME

Antibodies Against Extracellular Epitopes of Human TRPV6 Channel and their Diagnostic and Therapeutic Uses

USTEKINUMAB DOSAGE FORMS AND METHODS

ANTI-FAMILY WITH SEQUENCE SIMILARITY 19, MEMBER A5 ANTIBODIES AND METHOD OF USE THEREOF

C-TYPE NATRIURETIC PEPTIDE ENGRAFTED ANTIBODIES

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

TREATMENT OF CANCER USING A COMBINATION OF IMMUNOMODULATION AND CHECK POINT INHIBITORS

USE OF FSH-RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF ATHEROSCLEROSIS

METHODS AND MEANS FOR ATTRACTING IMMUNE EFFECTOR CELLS TO TUMOR CELLS

CDRS FOR GLYCOSYLATED ACAT1

ANDROGEN SUPPRESSION, PROSTATE-SPECIFIC MEMBRANE ANTIGEN AND THE CONCEPT OF CONDITIONALLY ENHANCED VULNERABILITY

ANTI-CD39 NANOBODY AND USES THEREOF

ANTI-CD40 ANTIBODIES AND USES THEREOF

TREATMENT FOR ACUTE MYELOID LEUKEMIA WITH ANTI-CD70 ANTIBODIES

ANTIBODIES TARGETING IL-18 RECEPTOR BETA (IL-18RB) AND RELATED METHODS

HUMANIZED ANTI-GDNF FAMILY ALPHA-RECEPTOR 4 (GRF-ALPHA-4) ANTIBODIES AND CHIMERIC ANTIGEN RECEPTORS

ANTI-EGFR ANTIBODIES, ANTI-CMET ANTIBODIES, ANTI-VEGF ANTIBODIES, MULTISPECIFIC ANTIBODIES, AND USES THEREOF

ANTI-DECTIN-1 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-MIC ANTIBODIES WITH VARIANT FC DOMAINS

A FUSION POLYPEPTIDE AND ITS USE

PHARMACEUTICAL COMPOSITION OF ANTI-TIM-3 ANTIBODY AND HYPOMETHYLATING AGENT

VARIANT ANTIBODIES THAT BIND GAMMA-DELTA T CELL RECEPTORS

HUMANIZED ANTIBODIES WITH INCREASED STABILITY

ANTI-CEACAM6 ANTIBODIES AND METHODS OF USE

TREATMENT OF MAST CELL RELATED DISORDERS

CONNEXIN 43 ANTIBODIES AND USE THEREOF

TREATMENT OF PERIVASCULAR FIBROSIS AND OTHER HYPERTENSIVE DISEASES AND CONDITIONS

TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-12/IL-23 INHIBITOR RELEASED USING AN INGESTIBLE DEVICE

Fc VARIANTS WITH ALTERED BINDING TO FcRn

COMPOSITIONS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

Antibodies to Botulinum Neurotoxins

A NOVEL H1N1 ANTIBODY

ANTIBODIES FOR TREATMENT OF CORONAVIRUS DISEASE

Fusion Molecules Of CTLA4 And IL-15

METHODS FOR INCREASING EFFICACY OF FOLR1 CANCER THERAPY

ANTI-CD3 ANTIBODY FORMULATIONS

MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER

COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1 INHIBITORS

METHODS OF TREATING FIBROSIS AND ARRHYTHMIA WITH A NEUREGULIN-1 FUSION PROTEIN

THERAPIES FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE

Methods and Products to Screen and Treat Glioblastoma Multiforme and Other Cancers, Including Breast Cancers, Using A Combination of PI3KINASE Inhibitors With Checkpoint Inhibitors

ANTI-CANCER COMBINATION THERAPY

ANTIBODY SPECIFICALLY BINDING TO ASM AND USE THEREOF

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2 POSITIVE CANCER

ANTI-MUC1 ANTIBODY-DRUG CONJUGATE

ANTIBODY VARIANTS AND USES THEREOF

TREATMENT OF DIABETES MELLITUS

BISPECIFIC ANTI-HUMAN A-BETA/HUMAN TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

Bispecific Natural Killer Engagers That Target Siglec-7

WNT SURROGATE MOLECULES AND USES THEREOF

FGFR2 INHIBITORS ALONE OR IN COMBINATION WITH IMMUNE STIMULATING AGENTS IN CANCER TREATMENT

MONOCLONAL ANTIBODIES AND BISPECIFIC ANTIBODY AGAINST C-MET

MULTISPECIFIC BINDING PROTEINS THAT BIND DECTIN-1 AND CD20 AND METHODS OF USE THEREOF

ANTI-FCRN ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF WITH IMPROVED STABILITY

HUMAN ANTIBODY OR ANTIGEN BINDING FRAGMENT THEREOF SPECIFIC AGAINST PD-L1 TO ENHANCE T-CELL FUNCTION

BISPECIFIC ANTI-CD28 X ANTI-CD22 ANTIBODIES AND USES THEREOF

CD19 BINDING MOLECULES AND USES THEREOF

BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN CHRONIC IMMUNE CONDITIONS

Compounds

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

MONOCLONAL ANTIBODY AGAINST NERVE GROWTH FACTOR, AND ENCODING GENE AND USE THEREOF

AAV VECTOR ENCODING ANTI-VEGF-A AND ANG-2 BISPECIFIC ANTIBODY

KINASE INHIBITORS, PREPARATION METHODS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TRANSPLANT-ASSOCIATED INJURY

PHARMACEUTICAL COMPOSITION, USE THEREOF, AND METHOD FOR TREATING CANCER

IMMUNOMODULATING TREATMENTS OF BODY CAVITIES

NOVEL ANTI-CD38 ANTIBODIES FOR THE TREATMENT OF CANCER

METHOD FOR PREDICTING PATIENT RESPONSE TO IMMUNOTHERAPY

COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER COMPRISING DDX54 INHIBITOR AND CANCER IMMUNOTHERAPY AGENT

METHODS OF ADMINISTERING FVIII MIMETIC BISPECIFIC ANTIBODIES ONCE WEEKLY

ACTIVATABLE MULTISPECIFIC MOLECULES AND METHODS OF USE THEREOF

ANTI-HER2/ANTI-CD47 MOLECULES AND USES THEREOF

ANTI-SIRPa ANTIBODIES AND THEIR THERAPEUTIC APPLICATIONS

ANTI-CD39 ANTIBODY

NOVEL SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) BINDING MOLECULES AND USES THEREOF